The Chemours Company
The Chemours Company (CC) Revenue
Annual & quarterly revenue history · segment & region breakdown
CC · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsThe Chemours Company trailing twelve-month (TTM) revenue is $5.82B, an increase of 0.45% year-over-year from $5.81B in FY2025.
Revenue trend
2025 – 2011 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $5.81B | +$0.03B | +0.45% |
| 2024-12-31 | $5.78B | -$0.30B | -4.87% |
| 2023-12-31 | $6.08B | -$0.75B | -11.02% |
| 2022-12-31 | $6.83B | +$0.49B | +7.66% |
| 2021-12-31 | $6.34B | +$1.38B | +27.69% |
| 2020-12-31 | $4.97B | -$0.56B | -10.08% |
| 2019-12-31 | $5.53B | -$1.11B | -16.75% |
| 2018-12-31 | $6.64B | +$0.46B | +7.36% |
| 2017-12-31 | $6.18B | +$0.78B | +14.50% |
| 2016-12-31 | $5.40B | -$0.32B | -5.54% |
Compare revenue vs peers
Chemicals - SpecialtyCompare CC revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income The Chemours Company receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
The Chemours Company reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from The Chemours Company's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CC revenue · 4 questionsCC's trailing twelve-month (TTM) revenue is $5.82B. That is an increase of 0.45% year-over-year from $5.81B in FY2025.
▸ Source: FMP · The Chemours Company SEC filings · GAAP · The Chemours Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026